S24 - Describe CGM Guided Management of People with T2D

Saturday, August 9, 2025

4:15 PM – 5:00 PM MT

CE/CME Hours: .75 CE

Pharmacology Hours: .50 CE

Primary Presenter(s)

GS

Gregg Simonson, PhD

Director, Strategy, Innovation and Partnerships
International Diabetes Center HealthPartners Institute
Minneapolis, Minnesota

Disclosure(s): Abbott Diabetes Care: My employer, HealthPartners Institue Interantional Diabetes Center, has received education grants (Ongoing); Sanofi: My employer, HealthPartners Institue Interantional Diabetes Center, has received education grants (Ongoing)

Co-Presenter(s)

Katrina Flaskerud, MS, RDN, LD, CDCES

Diabetes Care and Education Specialist
HealthPartners Diabetes Education Program
Chanhassen,, Minnesota

Disclosure(s): No financial relationships to disclose

Type 2 diabetes management is complex, and the landscape of therapy options is ever evolving. Diabetes care and education specialists (DCES) may lack confidence when recommending non-insulin therapy, titrating insulin, or having nutrition conversations based on continuous glucose monitoring (CGM) data. This session reviews resources developed by the International Diabetes Center to guide DCES in non-insulin therapy optimization, titrating basal, basal/bolus and premixed insulin treatment plans using CGM data, and having nutrition conversations with individuals using the Ambulatory Glucose Profile (AGP) Report. Attendees receive a hard copy and PDF of these resources and presenters will apply them to practice using a case study workbook coupled with facilitated discussion.

Disclosure(s):

Gregg Simonson, PhD: Abbott Diabetes Care: My employer, HealthPartners Institue Interantional Diabetes Center, has received education grants (Ongoing); Sanofi: My employer, HealthPartners Institue Interantional Diabetes Center, has received education grants (Ongoing)

Katrina Flaskerud, MS, RDN, LD, CDCES: No financial relationships to disclose